1 – 10 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes : A nested, case–control study
(
- Contribution to journal › Article
-
Mark
Effects of TCF7L2 rs7903146 variant on metformin response in patients with type 2 diabetes
(
- Contribution to journal › Article
- 2018
-
Mark
Mitochondrial medicine. New strategies to evaluate drug toxicity and develop pharmacological protection of the cell’s powerhouse.
2018)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Bioenergetic bypass using cell-permeable succinate, but not methylene blue, attenuates metformin-induced lactate production
(
- Contribution to journal › Article
-
Mark
Divergent effects of metformin on an inflammatory model of Parkinson’s disease
(
- Contribution to journal › Article
- 2017
-
Mark
Diabetes medication associates with DNA methylation of metformin transporter genes in the human liver
(
- Contribution to journal › Article
-
Mark
Evidence-based prioritisation and enrichment of genes interacting with metformin in type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Metformin treatment significantly enhances intestinal glucose uptake in patients with type 2 diabetes : Results from a randomized clinical trial
(
- Contribution to journal › Article
-
Mark
The Liver Circadian Clock Modulates Biochemical and Physiological Responses to Metformin
(
- Contribution to journal › Article
-
Mark
Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes
(
- Contribution to journal › Article